Trademark applications and grants for Loxo Oncology Inc. Loxo Oncology Inc has 12 trademark applications. The latest application filed is for "LOXO"
Patent Application | Date |
---|---|
FORMULATIONS OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6- -DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CAR- BONITRILE 20220202788 - 17/581219 REYNOLDS; Mark ;   et al. | 2022-06-30 |
METHODS OF DIAGNOSING AND TREATING CANCER 20220088021 - 17/533823 Tuch; Brian B. ;   et al. | 2022-03-24 |
FORMULATIONS OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6- -DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CAR- BONITRILE 20220087988 - 17/530019 REYNOLDS; Mark ;   et al. | 2022-03-24 |
COMPOUNDS USEFUL AS KINASE INHIBITORS 20220062239 - 17/525350 GUISOT; Nicolas | 2022-03-03 |
PROCESS FOR THE PREPARATION OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6- -DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CAR- BONITRILE 20210380609 - 17/401892 EARY; Charles Todd ;   et al. | 2021-12-09 |
SEC | 0001581720 | Loxo Oncology, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.